Anti-Human Papillomavirus 16 (E7)抗体[TVG 701Y] (ab20191)


  • 产品名称
    Anti-Human Papillomavirus 16 (E7)抗体[TVG 701Y]
    参阅全部 Human Papillomavirus 16 (E7) 一抗
  • 描述
    小鼠单克隆抗体[TVG 701Y] to人Papillomavirus 16 (E7)
  • 经测试应用
    适用于: WB, ELISA, Flow Cyt, IHC-Frmore details
  • 免疫原

    Full length protein (HPV 16 E7) synthesised from S. pombe.


  • 形式
  • 存放说明
    Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C or -80°C. Avoid freeze / thaw cycle.
  • 存储溶液
    Preservative: None
    Constituents: PBS
  • Concentration information loading...
  • 纯度
    IgG fraction
  • 克隆
  • 克隆编号
    TVG 701Y
  • 骨髓瘤
  • 同种型
  • 研究领域


Our Abpromise guarantee covers the use of ab20191 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

应用 Ab评论 说明
WB Use at an assay dependent concentration. Predicted molecular weight: 15 kDa.
ELISA Use at an assay dependent concentration.
Flow Cyt Use at an assay dependent concentration. ab170191-Mouse monoclonal IgG2a, is suitable for use as an isotype control with this antibody.
IHC-Fr Use at an assay dependent concentration.


  • 相关性
    E7 protein has both transforming and trans-activating activities. Disrupts the function of host retinoblastoma protein RB1/pRb, which is a key regulator of the cell cycle. Induces the disassembly of the E2F1 transcription factors from RB1, with subsequent transcriptional activation of E2F1-regulated S-phase genes. Inactivation of the ability of RB1 to arrest the cell cycle is critical for cellular transformation, uncontrolled cellular growth and proliferation induced by viral infection. Stimulation of progression from G1 to S phase allows the virus to efficiently use the cellular DNA replicating machinery to achieve viral genome replication. Interferes with histone deacetylation mediated by HDAC1 and HDAC2, leading to activation of transcription
  • 细胞定位
  • 别名
    • E7 antibody
    • HPV16 E7 antibody
    • Protein E7 antibody
    • Transforming protein antibody

Anti-Human Papillomavirus 16 (E7) antibody [TVG 701Y] (ab20191)参考文献

This product has been referenced in:
  • Harris M  et al. Combined treatment of the experimental human papilloma virus-16-positive cervical and head and neck cancers with cisplatin and radioimmunotherapy targeting viral E6 oncoprotein. Br J Cancer 108:859-65 (2013). Read more (PubMed: 23385729) »
  • Tommasino M  et al. HPV16 E7 protein associates with the protein kinase p33CDK2 and cyclin A. Oncogene 8:195-202 (1993). Read more (PubMed: 8380917) »

See all 2 Publications for this product

Product Wall

Thank you for contacting us and for your patience.

The supplying lab let us know the following:

We do not have a protocol sincewe are provided our antibodies by outside scientists and we tend to see only the information that is prov...

Read More

Thank you for your enquiry and your interest in our products.

These two monoclonal antibodies recognize the same protein (Human Papillomavirus 16 (E7)) but are from different clones.


Read More

Thank you for your enquiry. I am pleased to help answer your questions.

1. I have contacted the originator and regrettably they are not able to provide any further information on the immunogen on this occasion.We aim to provide as much infor...

Read More

Thank you for your call today and for your questions about ab20191.

I have done a search on google scholar for the clone TVG 701Y, and there are several publications listed:

Read More

Thank you for contacting Abcam.   I have contacted the lab about ab20191, which is a Human Papillomavirus 16 (E7) antibody [TVG701Y] and can be used in flow cytometry and western blot. However the lab has told me that we do not know what the immunogen ...

Read More